{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T08:09:25Z","timestamp":1784621365449,"version":"3.55.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005046","name":"Heilongjiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LH2022H013"],"award-info":[{"award-number":["LH2022H013"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fitoterapia"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.fitote.2025.106931","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T22:47:41Z","timestamp":1760395661000},"page":"106931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Design, synthesis and anti-breast tumor activity of Berberine hydrogen sulfide donor derivatives"],"prefix":"10.1016","volume":"187","author":[{"given":"Zhixiong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weina","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.fitote.2025.106931_bb0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41416-020-01161-4","article-title":"The lingering mysteries of metastatic recurrence in breast cancer","volume":"124","author":"Riggio","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.fitote.2025.106931_bb0010","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s11427-021-2009-0","article-title":"Cancer challenges worldwide and in China: preparing for the inevitable","volume":"65","author":"Zhou","year":"2022","journal-title":"Sci. China Life Sci."},{"issue":"12","key":"10.1016\/j.fitote.2025.106931_bb0015","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11864-019-0685-7","article-title":"Diagnosis and treatment of breast Cancer in young women","volume":"20","author":"Rossi","year":"2019","journal-title":"Curr. Treat. Options in Oncol."},{"issue":"10","key":"10.1016\/j.fitote.2025.106931_bb0020","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/bjc.2014.388","article-title":"HER2-positive advanced breast cancer: optimizing patient outcomes and opportunities for drug development","volume":"111","author":"Singh","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.fitote.2025.106931_bb0025","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3390\/cancers12040916","article-title":"The landscape of targeted therapies in TNBC","volume":"12","author":"Vagia","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.fitote.2025.106931_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1446414","article-title":"HER2-targeted therapies for HER2-positive early-stage breast cancer: present and future","volume":"15","author":"Xu","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.fitote.2025.106931_bb0035","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s12282-024-01567-5","article-title":"PI3K\/AKT\/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer","volume":"31","author":"Zhang","year":"2024","journal-title":"Breast Cancer"},{"issue":"4","key":"10.1016\/j.fitote.2025.106931_bb0040","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.drudis.2015.12.003","article-title":"COX-2 inhibitors: a novel strategy in the management of breast cancer","volume":"21","author":"Regulski","year":"2016","journal-title":"Drug Discov. Today"},{"issue":"2","key":"10.1016\/j.fitote.2025.106931_bb0045","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1159\/000487171","article-title":"Berberine suppresses cell motility through downregulation of TGF-\u03b21 in triple negative breast Cancer cells","volume":"45","author":"Kim","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.fitote.2025.106931_bb0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4048\/jbc.2018.21.1.21","article-title":"Berberine suppresses fibronectin expression through inhibition of c-Jun phosphorylation in breast Cancer cells","volume":"21","author":"Jeong","year":"2018","journal-title":"J. Breast Cancer"},{"issue":"29","key":"10.1016\/j.fitote.2025.106931_bb0055","doi-asserted-by":"crossref","first-page":"45849","DOI":"10.18632\/oncotarget.9968","article-title":"Tumor suppressor berberine binds VASP to inhibit cell migration in basal-like breast cancer","volume":"7","author":"Su","year":"2016","journal-title":"Oncotarget"},{"issue":"14","key":"10.1016\/j.fitote.2025.106931_bb0060","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.3390\/molecules27144523","article-title":"Anticancer effects and mechanisms of Berberine from medicinal herbs: an update review","volume":"27","author":"Xiong","year":"2022","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.fitote.2025.106931_bb0065","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3390\/biom10020323","article-title":"Hydrogen sulfide in pharmacotherapy, beyond the hydrogen sulfide-donors","volume":"10","author":"Zaorska","year":"2020","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.fitote.2025.106931_bb0070","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7150\/ijbs.47850","article-title":"Role of hydrogen sulfide donors in cancer development and progression","volume":"17","author":"Ngowi","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.fitote.2025.106931_bb0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jare.2020.07.006","article-title":"Targeting hydrogen sulphide signaling in breast cancer","volume":"27","author":"Youness","year":"2020","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.fitote.2025.106931_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101564","article-title":"Hydrogen sulfide and its donors: novel antitumor and antimetastatic therapies for triple-negative breast cancer","volume":"34","author":"Li","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.fitote.2025.106931_bb0085","article-title":"Berberine and Emodin abrogates breast cancer growth and facilitates apoptosis through inactivation of SIK3-induced mTOR and Akt signaling pathway","volume":"2020","author":"Ponnusamy","year":"1866","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"key":"10.1016\/j.fitote.2025.106931_bb0090","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.canlet.2019.04.031","article-title":"A novel hydrogen sulfide-releasing donor, HA-ADT, suppresses the growth of human breast cancer cells through inhibiting the PI3K\/AKT\/mTOR and Ras\/Raf\/MEK\/ERK signaling pathways","volume":"455","author":"Dong","year":"2019","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.fitote.2025.106931_bb0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1021\/ja1085723","article-title":"Cysteine-activated hydrogen sulfide (H2S) donors","volume":"133","author":"Zhao","year":"2011","journal-title":"J. Am. Chem. Soc."}],"container-title":["Fitoterapia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0367326X2500557X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0367326X2500557X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T11:09:48Z","timestamp":1778324988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0367326X2500557X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":19,"alternative-id":["S0367326X2500557X"],"URL":"https:\/\/doi.org\/10.1016\/j.fitote.2025.106931","relation":{},"ISSN":["0367-326X"],"issn-type":[{"value":"0367-326X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and anti-breast tumor activity of Berberine hydrogen sulfide donor derivatives","name":"articletitle","label":"Article Title"},{"value":"Fitoterapia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fitote.2025.106931","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106931"}}